Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: Potential use as a marker for joint cartilage damage

Modern Rheumatology

Volumn 14, Issue 5, 2004, Pages 356-360

  Momohara, Shigeki ^a   Yamanaka, Hisashi ^a   Holledge, Masumi Maruo ^a   Mizumura, Tamao ^a   Ikari, Katsunori ^a   Okada, Naoyuki ^a   Kamatani, Naoyuki ^a   Tomatsu, Taisuke ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Biomarker; Cartilage oligomeric matrix protein (COMP); Matrix metalloproteinase 3 (MMP 3); Rheumatoid arthritis (RA)

Indexed keywords

C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; PREDNISOLONE; STROMELYSIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BLOOD SAMPLING; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GROUPS BY AGE; HUMAN; KNEE ARTHROPLASTY; KNEE ARTHROSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYNOVECTOMY; SYNOVIAL FLUID LEVEL;

EID: 8444235539     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-004-0323-4     Document Type: Article

References (20)

1. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum 2001;44:2009-17.
2. Chen H, Deere M, Hecht JT, Lawler J. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. J Biol Chem 2000;275: 26538-44.
3. Oldberg A, Antonsson P, Lindblom K, Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992;267:22346-50.
4. Rosenberg K, Olsson H, Morgelin M, Heinegard D. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 1998;273:20397-403.
5. Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, Heinegird D, et al. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasis and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 2001;276:6083-92.
6. Holden P, Meadows RS, Chapman KI, Grant ME, Kadler KE, Briggs MD. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 2001; 276:6046-55.
7. Newton G, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, et al. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 1994;24:435-9.
8. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins: An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992;267:6132-6.
9. Saxne T, Heinegård D. Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
10. Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, et al. Serum matrix metalloproteinase-3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
11. Ochi T, Iwase R, Yonemasu K, Matsukawa M, Yoneda M, Yukioka M, et al. Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis Rheum 1988;31:37-43.
12. Larsen A. A radiological method for grading the severity of rheumatoid arthritis. Scand J Rheumatol 1975;4:225-33.
13. Forslind K, Eberhardt K, Jonsson A, Saxne T. Increased serum concentrations of cartilage oligomeric matrix protein: A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992;31:593-8.
14. Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein: A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003;32:156-61.
15. Crnkic M, Mansson B, Larsson L, Geborek P, Heinegard D, Saxne T. Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 2003;5:R181-5.
16. Roux-Lombard P, Eberhardt K, Saxne T, Dayer JM, Wollheim FA. Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: Relationship to radiological progression and inflammation in early rheumatoid arthritis; a prospective 5-year study. Rheumatology (Oxford) 2001;40:544-51.
17. Fex E, Eberhardt K, Saxne T. Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. Br J Rheumatol 1997;36:1161-5.
18. Mansson B, Geborek P, Saxne T. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: Relation to development of knee or hip joint destruction. Ann Rheum Dis 1997;56:91-6.
19. Wollheim FA, Eberhardt KB, Johnson U, Saxne T. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Br J Rheumatol 1997;36:847-9.
20. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151-60.